Cytotoxic activity of aquatic fungus Pseudohalonectria lignicola on two different human cell lines

Planta Medica ◽  
2014 ◽  
Vol 80 (16) ◽  
Author(s):  
S Schneider ◽  
N Srirangan ◽  
M Wurster ◽  
U Lindequist ◽  
M Lalk
2007 ◽  
Vol 4 (1) ◽  
pp. 20-27 ◽  
Author(s):  
Sri Nurestri Abd Malek ◽  
Norhanom Abdul Wahab ◽  
Hashim Yaacob ◽  
Sim Kae Shin ◽  
Hong Sok Lai ◽  
...  

2012 ◽  
Vol 7 (8) ◽  
pp. 1934578X1200700 ◽  
Author(s):  
Luis A. Sánchez ◽  
Dionisio Olmedo ◽  
José Luis López-Pérez ◽  
Todd D. Williams ◽  
Mahabir P. Gupta

In the course of our search for antineoplasic agents from Panamanian Flora, two new alkylresorcinols: 1-(2,6-dihydroxyphenyl)octan-1-one (1) and (+)-1-(3-(1-(2,6-dihydroxyphenyl)butyl)-2,6-dihydroxyphenyl)octan-1-one (2), together with three known compounds, (1 R, 2 R)-1-(benzo[ d][1,3]dioxol-5-yl)propane-1,2,3-triol (3), (+)-aptosimon (4) and (-)-sesamin (5), were identified from the leaves of Homalomena wendlandii Schott (Araceae). Their structures were established by 1D and 2D NMR and IR spectroscopic, and MS methods. Compound 2 exhibited IC50 values of 3.3, 5.8 and 4.0 μg/mL against MCF-7, SF-268 and H-460 cancer human cell lines, respectively.


2008 ◽  
Vol 3 (8) ◽  
pp. 1934578X0800300
Author(s):  
Mona M. Marzouk ◽  
Salwa A. Kawashty ◽  
Lamyaa F. Ibrahium ◽  
Nabiel A. M. Saleh ◽  
Abdel-Ssalam M. Al-Nowaihi

Two new kaempferol glycosides, kaempferol 3- O-(2″-α-L-rhamnopyranosyl)-β-L-arabinopyranoside-7- O-α-L-rhamnopyranoside and kaempferol 3- O-(2″-α-L-rhamnopyranosyl)-β-L-arabinopyranoside-7- O-α-L-rhamnopyranoside-4′- O-β-D-glucopyranoside were isolated along with four known flavonols from Matthiola longipetala (subsp. livida) (Delile) Maire growing in Egypt. Their structures were established on the basis of detailed chemical and spectral analysis. The cytotoxic activity of the alcoholic extract against Cervix (HELA) and Colon (HCT116) human cell lines showed IC50 values of 22.1 and 53.7 μg/mL, respectively. No activity was found against liver (HEPG2) carcinoma cells.


2010 ◽  
Vol 65 (9-10) ◽  
pp. 577-587 ◽  
Author(s):  
Galal H. Elgemeie ◽  
Elsayed M. Mahdy ◽  
Mona A. Elgawish ◽  
Mohammad M. Ahmed ◽  
Wafaa G. Shousha ◽  
...  

The present study was designed for highlighting and focusing on the cytotoxic activity of a new class of antimetabolites both on human cell lines, namely liver carcinoma cell line (Hepg2), lung carcinoma cell line (H460), breast carcinoma cell line (MCF7), brain carcinoma cell line (U251), and animal cell line EAC (Ehrlich ascites carcinoma cells). The results revealed that some of these modified deazapyrimidine thioglycosides have significant cytotoxic activity against EAC cells with growth inhibition percentage ranged between 80% to 90%. The possible inhibitory mechanism of the pyridine thioglycosides was explored by studying the cell cycle perturbation of thioglycosides against human cell lines (in vitro) as well as the most suitable time for maximum compound cytotoxic activity after 6, 18, and 24 h of incubation. To confirm the cytotoxic activity of these compounds, they have been tested for their apoptotic and antiproliferative activity in vivo against solid Ehrlich tumours using five groups of Swiss albino mice for 37 days from inoculation and three treatments, 250, 500 and 1,000 μg/kg body weight. There was signifi cant reduction in Ehrlich tumour size in case of the 500 and 1,000 μg/kg body weight group but mild significant tumour reduction in the 250 μg/kg body weight group. Histograms of DNA per cell for each treatment group indicated that there was a dose-dependent increase in the preG1 phase with a corresponding complete arrest of cells from entering the G2/M phase compared to the untreated EAC group. In conclusion, pyridine thioglycosides have proven good cytotoxic effects against EAC cells and also significant cytotoxic activity against the four tested human cell lines. Flow cytometric DNA ploidy analysis of pyridine thioglcyosides against the Hepg2 and U251 cell lines revealed that the postulated mechanism of action of pyridine thioglcyosides is cell cycle arrest in the S phase. This is similar to antimetabolites and cell cycle arrest in the G2/M phase (M phase) in the same way as microtubule inhibitors like pyridine thioglycosides are cell-cycle-specific in the S phase and the M phase (in case of human cell lines) and have apoptotic effects (in case of animal cell line).


Sign in / Sign up

Export Citation Format

Share Document